AS PART OF A CAPA INVESTIGATION, IT WAS DETERMINED THAT COMPLAINT NUMBER (B)(4) IS RELATED TO A FOREIGN RECALL OF A PRODUCT ONLY AVAILABLE IN (B)94). DUE TO THE SIMILARITY TO A U.S PRODUCT, IN AN ABUNDANCE OF CAUTION, QIAGEN IS FILING A REPORT.
D
Patient 1
CUSTOMER COMPLAINT RECEIVED STATING HIGH RATE OF POSITIVE AND GREY-ZONE RESULTS FOR RECRUIT TB SCREENING TESTS SEEN AT 2 SITES.